GLOBAL: Global Fund Approves $2.4 Billion to Fight AIDS, TB, Malaria CDC Daily UpdateImportant note: Information in this article was accurate in 2009. The state of the art may have changed since the publication date.

Click here to return to CDC Daily Update main menu





DonateNow



GLOBAL: Global Fund Approves $2.4 Billion to Fight AIDS, TB, Malaria

Voice of America News (11.15.09) - Tuesday, November 17, 2009
Peter Heinlein


At their meeting last week, the directors of the Global Fund to Fight AIDS, TB and Malaria approved its second-largest round of grants to fight the diseases. Recommended funding totaled $2.4 billion over two years, $350 million less than last year's $2.75 billion, which was approved before the global economic downturn.

However, the Global Fund may be unable to sustain even this reduced level, said Executive Director Michel Kazatchkine, unless wealthy countries and donors increase their commitments.

"We are seeing a tremendous demand for funding," Kazatchkine said. "Countries are showing that they are able to effectively turn large amounts of money from donors into prevention, care and treatment of AIDS, TB and malaria, which in turn will save millions of lives. It also means that we need significantly more resources in the future. We may not be able to continue approving such amounts of financing and see continued progress in health in the coming years unless donor countries scale-up their funding even further than what they have done so far."

The board decided to launch the next round of grants in May 2010, with recommendations for approvals to follow between November 2010 and January 2011. During the meeting, Dr. Tedros Adhanom Ghebreyesus, Ethiopia's health minister, was elected to chair the board next year.

"These grants enable countries around the world to address some of the main problems they are struggling with every day," Ghebreyesus said. "These grants are based on the countries' own needs and priorities and they are therefore a particularly effective source of financing."
091117
AD091968


Copyright © 2009 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.

.